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Abstract 
 
Aims.  Although socioeconomic background is known to impact on the incidence and 
progression of chronic kidney disease, its influence of on the presentation and 
outcome for acute kidney injury is not known, and is the subject of this study 
 
Design. The	Welsh	National	electronic	AKI	reporting	system	was	used	to	identify	
all	 cases	 of	 AKI	 in	 patients	 >18yrs	 of	 age	 between	March 2015 and November 
2017.   
 
Methods: Socioeconomic classification of patients was derived from the Welsh Index 
Multiple Deprivation score (WIMD).  Patients were grouped according to the WIMD 
score by their postcode, and the ranked data were categorised into percentiles and 
correlated with incidence, and measures of AKI severity and outcome.  	
 
Results. Date was collected on a total of 57 654 patients.  Increased deprivation was 
associated with higher AKI incidence rates, more episodes of AKI per patient and 
more severe AKI at presentation.  In contrast 90-day mortality was highest in the most 
affluent areas.  Mortality in affluent areas was driven by increased patient age.  
Corrected for age 90-day mortality was higher in areas of increased deprivation.   
 
Conclusions. This study highlights that AKI incidence presentation and outcomes are 
adversely affected by social deprivation.  Further studies are required to understand 
the extent to which these differences reflect patient related factors or regional 
differences in provision and access to care.   
 
 
 
 
 
 
 
 
  
Introduction 
Acute Kidney Injury (AKI) is characterized by a sudden decline in renal function 
which is associated with increased patient morbidity and mortality (1).  In patients 
surviving an acute episode, AKI is also associated with longer term effect on patient’s 
health as there is an increase in incidence of subsequent Chronic Kidney disease and a 
higher mortality than in patients who have not experienced AKI (2). The increasing 
incidence of AKI is well documented.  Furthermore, a recent study of AKI in Wales 
suggest that there is an association between the incidence of AKI and measures of 
social deprivation. with a higher incidence of AKI in those from socially deprived 
areas (3).  
 
The relationship between Socioeconomic deprivation and higher mortality and 
reduced life expectancy in the UK are well established (4).  A higher incidence and 
worse clinical outcomes related to social deprivation have been described for a 
number of medical conditions including coronary heart disease (5, 6) and the most 
common forms of cancer (7-10). 
 
In Renal Medicine the relationship between socioeconomic deprivation, severity of 
chronic kidney disease (CKD) and poor clinical outcomes is well documented (11-
16), as are the effects of social deprivation in renal transplantation (17-19).  Whilst 
some aspects of the impact of social deprivation on renal disease have therefore been 
described, its impact on the incidence and severity of AKI at presentation and 
outcome following AKI has not been previously reported.  This study aims to 
describe the relationship between social deprivation and the severity of AKI at 
presentation and clinical measures of outcome. 
 
 
Methods 
Setting 
Data was collected from the seven health boards in the National Health Service in 
wales, representing a population of 3.06 million people. The Medical Record Number 
(MRN) was used as the patient identifier. This unique reference number is allocated 
to patients registered in the National Laboratory Information Management System 
(LIMS) which therefore allows for multiple visits/blood test requests to be linked.  
The study has been approved under the conditions of ‘Service Evaluation Project 
Registration’. 
 
The Electronic AKI reporting system  
The Welsh electronic reporting system generates an AKI alert by comparing a current 
creatinine value to historic creatinine measurements for the same patient in real time.  
It defines AKI according to KDGIO increase in creatinine parameters (3).  Patients 
who have an AKI episode but no previous recorded creatinine values will not be 
alerted by this system.   
 
Data Collection 
Data was collected on all individuals over the age of 18 years old for which an AKI 
alert was generated in any location across Wales between March 2015 and November 
2017. Patients receiving renal replacement therapy and patients with a known renal 
transplant, and AKI alerts generated on the renal tertiary center base ward were 
excluded from the analysis to avoid spurious labelling of AKI resulting from 
fluctuations in serum creatinine related to renal replacement therapy as previously 
described (3).  An incident AKI episode was defined as 30 days, and the first AKI 
alert was defined as the incident alert (i.e., any AKI e-alert for the same patient within 
30 days of the incident alert was not considered a new episode).    
 
In addition to measurements of renal function data was collected on patient age, 
gender, stage of AKI, pre-existing CKD (eGFR calculated by the Chronic Kidney 
Disease Epidemiology Collaboration eGFR equation (20)) <60ml/min per 1.73 m2 
derived from the baseline SCr) and the clinical location at which the alert was 
generated.   
 
All	patients	for	which	the	first	alert	was	issued	during	a	hospital	admission	
who	also	had	a	normal	SCr	value	generated	in	a	hospital	setting	within	the	
preceding	 seven	 days	 were	 defined	 as	 Hospital	 acquired	 (HA)-AKI.	
Conversely patients who had an alert in a setting outside of hospital were defined as 
having Community acquired AKI (CA-AKI). For the CA-AKI when the follow up 
measurement (first or second measurement) of renal function was in a hospital setting 
the patient was defined as hospitalised CA-AKI. 
 
Progression of AKI (defined as a peak AKI stage higher that the incident AKI stage or 
for stage 3 alerts an increase≥50% from the SCr generating the alert), renal function at 
90 days and patient mortality at 90 days were collected as measures of clinical course 
and impact of AKI.  Non recovery of renal function was defined as a serum creatinine 
level at 90 days, which remained above the serum creatinine baseline which remained 
consistent with a definition of AKI.  
 
The day on which the incident AKI alert was generated was also recorded in order to 
generate two patient groups: those generating an AKI at the weekend and those 
generating an alert on a weekday.   
 
Contact with medical services prior to the AKI episode was determined by recent 
measurement of renal function defined as a measurement of renal function within the 
preceding 30 days of the incident AKI alert.   
 
Incidence rate was calculated using Mid-2013 Office for National Statistics (ONS) 
Population Estimates and patient level post code analyses (21).  Data on patient 
mortality were collected from the Welsh Demographic Service (22).  Socioeconomic 
classification of patients was derived from the Welsh Index Multiple Deprivation 
score (WIMD). This is the Welsh Government’s official measure of relative 
deprivation in which the population of Wales is divided into 1909 geographical units 
called lower super output areas (LSOAs) each with an average population of 1600 
people (23).  The WIMD score is constructed from a weighted sum of the deprivation 
score for each of the following domains: Income (23.5%),  Employment  (23.5%), 
Health (14.0%), Education (14.0%), Access to Services (10.0%), Community Safety 
(5.0%), Physical Environment (5.0%), Housing (5.0%).   Patients were grouped 
according to the WIMD score by their postcode and corresponding LSOA of 
residence, and the ranked data were categorised into percentiles, with percentile 1 
being the most socio-economically deprived and percentile 100 being the least 
deprived.  
 
Statistical analysis was carried out using SPSS software, version 20 (IBM SPSS, 
Chicago, I); Pearsons Coefficient was calculated to determine correlation between 
measures of social deprivation of AKI readouts.  Multivariate Cox proportional 
hazard modeling was used to analyze patient survival. P values <0.05 were considered 
statistically significant. 
 
Results 
Incidence and Demographics. 
A total of 57 654 patients triggered and electronic AKI alert between March 2015 and 
2017.  In total there were incident alerts equating to an average of 1.45 AKI episodes 
per patient.  The incidence of AKI during this time period was 4.1 patients per 1000 
population per year. The average age of the patient was 71.05±17.0 yrs.  Overall 90-
day mortality for the whole cohort was 25.8%.  The majority (78.47%) of episodes 
were classified as AKI stage 1 at presentation, with 14.5% classified as AKI stage 2 
and 7.03% classified as AKI stage 3; 30.4% of patients had pre-existing CKD.  49.8% 
and 38.5% of patients first presented with CA-AKI and HA-AKI respectively. 11.7% 
patients whilst alerting in an in-patient setting had no results for the previous 7 days, 
and therefore could not be confidently designated as either CA- or HA-AKI 
definitions, and excluded from the subgroup analysis.   
  
Relationship between socioeconomic status and presentation.   
The relationship between incidence of AKI and patient socioeconomic status is shown 
in Figure 1. There was a strong negative correlation between ranking by WIMD score 
and the incidence of AKI (r=-0.805; 95% CI, -0.924 to -0.687; P<0.001). There was 
also a negative association between the number of AKI episodes per patient and 
socioeconomic measures (r=-0.301; 95% CI, -0.492 to -0.109; p=0.002; Figure 1D). 
The negative correlation between ranking by WIMD and AKI incidence also seen in 
subgroup analysis of CA- (R=-0.759; 95% CI, -0.889 to -0.628; P<0.001) and HA-
AKI (R=-0.730; 95% CI, -0.867 to -0.593; P<0.001).  Although weekend presentation 
to hospital has previously been reported to be associated with social deprivation, 
whilst there was no relationship between the day of diagnosis of AKI and socio-
economic measures in the whole cohort (R= 0.116; 95% CI, -0.083 to 0.315; p=n/s: 
Figure 2A), there was a negative correlation between weekend detection and 
socioeconomic deprivation in the CA-AKI subgroup (R= -0.266; 95% CI, -0.459 to -
0.073; p=0.008; Figure 2B).    
 
Mortality and socioeconomic status. 
The relationship between socioeconomic measures and 90-day mortality following 
AKI is shown in Figure 3. In contrast to the relationship between incidence of socio-
economic deprivation, there was a strong positive correlation between ranking by 
WIMD score and the 90-day mortality with a higher proportion of AKI patients dying 
within 90 days of presentation in the most socially affluent areas (R= 0.312; 95% CI, 
0.122 to 0.503; P=0.002).  This positive relationship between mortality and socio-
economic measures was seen in both CA-AKI and HA-AKI (Figure 3B and 3C).   
 
Kaplan-Meier survival curves by WIMD quartile are shown in Figure 4, with Quartile 
1 representing the most socially deprived and Quartile 4 the most affluent 
geographical areas.  Mean survival was longest in the most deprived WIMD quartile 
(475.5 days, 95% CI 471.1-479.8) and fell progressively in each WIMD quartile 
representing increasing affluence (2
nd
 quartile 467.1 days, 95%CI 463.0-471.3, 3
rd
 
quartile 462.9 days, 95% CI 458.5-467.2, 4
th
 quartile 459.3 days, 95% CI 454.4-
463.9, Chi
2
 31.64, p<0.0001).   
 
 
 
AKI severity and socioeconomic status.   
Severity of AKI at presentation was determined by the % of patients with AKI stage 2 
or 3 at presentation and also by the proportion of patients who progressed to a higher 
AKI stage following initial diagnosis (Figure 5).  There was a weak negative 
correlation between ranking by WIMD score and the severity at presentation. This 
was true when assessing severity as either the percentage of patients presenting with 
AKI stage 3 (R= -0.201; 95% CI, -0.398 to -0.005; P=0.045) or the combined 
percentage presenting with AKI2 and 3 (R= -0.217; 95% CI, -0.413 to -0.022; 
p=0.03).  This relationship held true for CA-AKI (Figure 5B) but not for HA-AKI 
(Figure 5C).  In contrast severity of disease as assessed by progression of AKI to a 
higher stage was not significantly related to measures of social deprivation (Figure 
5D).  
 
Patient demographics 
The relationship between age at presentation of AKI and patient socioeconomic status 
is shown in Figure 6. There was a strong positive correlation between ranking by 
WIMD score and the age of patients presenting with AKI (R= 0.876; 95% CI, 0.780 
to 0.973; P<0.001: Figure 6A). This strong positive relationship was also seen in both 
the CA-AKI (R= 0.855; 95% CI, 0.751 to 0.959; P<0.001; Figure 6B) and HA-AKI 
(R= 0.807; 95% CI, 0.689 to 0.926; P<0.001: Figure 6C).  
 
Cox regression proportional hazard modeling analysis was used to assess corrected 
patient mortality.  For the whole cohort higher hazard of death was associated with 
older age (HR, 1.037; 95% CI, 1.036-1.38; p<0.001) and a higher WIMD ranking (i.e. 
less social deprivation) (HR, 1.001;95% CI, 1.001–1.002; p<0.001). Adjusted for age 
however the HR of death was lower in patients with higher WIMD ranking (adjusted 
HR, 0.999; 95% CI, 0.998–0.999; p<0.001). 
 
Kaplan-Meier survival curves for patients aged <65 years of age and ≥65 years of age 
by WIMD quartile are shown in Figure 7, with Quartile 1 representing the most 
socially deprived and Quartile 4 the most affluent geographical. For the patients aged 
<65 years there was no effect of social deprivation and mean survival. Mean survival 
was no different between the highest and lowest WIMD quartiles (WIMD Quartile: 1 
577.9 days 95%CI 574.4-585.6, Quartile 4: 579.5 95%CI 575.2-581.8, Chi
2
 5.03, 
p=0.169).  For older patients, aged ≥65year at the time of the AKI episode, mean 
survival was significantly shorter in the most deprived WIMD quartiles (Mean 
survival; Quartile 1: 419.0 days, 95%CI 413.8-424.2; Quartile 2: 412.3 days, 95%CI 
416.3-426.4, Quartile 3: 428.9 days, 95%CI 423.8-434.1, Quartile 4: 426.7 days 
95%CI 421.3-432.1, Chi
2
 9.05, p=0.029)  
 
 
Pre-existing CKD was used as a surrogate marker of co-existing co-morbidities 
(Figure 8A). There was a positive correlation seen between the proportion of AKI 
patients with pre-existing CKD and WIMD ranking. (R= 0.546; 95% CI, 0.378 to 
0.714; P<0.001). A previous measure of renal function in the month prior to 
presentation of CA-AKI was used as a surrogate marker of recent medical contact 
again reflecting likely co-existing co-morbidity (Figure 8B).  There was also a 
significant positive association between prior measurement of renal function and 
WIMD ranking (R= 0.403; 95% CI, 0.222 to 0.591; P<0.001). 
 
 
Discussion 
 
The striking finding of this study is that despite the incidence of AKI being lower in 
the more affluent areas, mortality is higher. This excess in mortality is not explained 
by the severity at presentation as AKI at presentation is more severe in the socially 
deprived areas and tend to be milder in the more affluent cohort. The data however 
suggest that excess AKI related mortality in affluent areas is related to the older age 
of the patients in the affluent areas presenting with AKI.  
 
It is well recognized that we have an ageing population, which reflects the benefit of 
efforts to improve population health. Despite this, an aging population does bring 
additional challenges, a key one of which is frailty. Frailty is a distinctive health state 
related to the ageing process in which multiple body systems gradually lose their in-
built reserves. Around 10% of people aged over 65 years have frailty, rising to 
between a quarter and a half of those aged over 85 years.  Our data suggest that the 
mortality in AKI in affluent areas may provide another measure of frailty in the aging 
population.  Previous data defining the epidemiology of AKI in Wales demonstrated 
increased higher hazards of death associated with older age (3).  The current data 
reflects this in that the AKI associated mortality in the affluent areas is a reflection of 
increased life expectancy and an aging population.  In order to reduce AKI associated 
mortality in this patient group, clinicians need to understand the significance of small 
changes in serum creatinine particularly in an elderly population.  Clinicians 
responding to an electronic AKI alert, should be encouraged to undertake early 
clinical assessment of acute illness and volume status, prompt review of medications 
with temporary cessation of nephrotoxic medications where appropriate.  
 
Our linear regression analysis also demonstrates that once corrected for age, there is 
a higher likelihood of death in the areas of social deprivation, most pronounced in the 
older patient group as shown in the Kaplan Meier survival data in the older 
patient group.  This needs to be quailed by the finding that the effect of age on 
survival was not liners for each WIMD quartile as survival in the second quartile 
was shorter that the first and most deprived quartile.   The association between 
social deprivation and increase mortality is well described.  Data from Wales which 
includes some of the poorer areas in Europe, demonstrate fundamental inequalities 
between the poorest and wealthiest (24).  Men from poorer areas of Wales die 8.8 
years earlier and women 7.2 years earlier than their wealthier neighbors.  This is 
associated with a higher incidence of smoking, obesity, poor diet, inactivity and 
alcohol consumption (25-27).  These are risk factors are aetiologically linked to the 
four diseases that account for 64% of early deaths; cancer, heart disease, stroke and 
diabetes.  As a result, the difference the “healthy life expectancy” within Wales is 
18.7 years for men and 18.2 years for women in the least affluent areas.  This suggests 
that socioeconomic deprivation is associated with “premature ageing”.   Previous 
studies based in South Wales have demonstrated that age and pre-existing CKD are 
the most useful variables which can be used to predict the likelihood of developing 
AKI (28).  Given the evidence suggesting premature aging in the socially deprived 
cohort what we consider to be “old” may need to be redefined and it is not simply a 
question of “years”.  In this study correction for age in a linear regression model also 
demonstrates inequality of outcome.  In the socially deprived areas the weight of all 
“early onset” of chronic conditions such as cardiovascular disease, diabetes and 
obesity leads to a poorer outcome for AKI in the poorer areas, suggesting that 
mortality in AKI in socially deprived areas reflects the increased burden of co-
morbidity.  The burden of co-morbidity and poor outcome has also been described in 
other aspects of nephrology, with social deprivation being associated with poor 
outcome in CKD, with higher rates of progression of CKD and also poor outcomes 
once on dialysis (11-13).  Outcome following renal transplantation also follows the 
same pattern with a higher rate of post-operative complications and poorer outcomes 
associated with social deprivation (17).  This is also consistent with the literature 
related to cardiovascular disease where it is recognized that socio-economic 
deprivation is a marker of poor outcome following coronary artery disease. Patients 
undergoing coronary artery bypass grafting from socially deprived areas tend to be 
younger, have more risk factors and as a result have a worse outcome postoperatively 
due to increased risk of complications (5, 6).   Most chronic diseases are preventable 
and adopting four of five “healthy behaviors” such as increasing exercise, reducing 
smoking and alcohol intake and modification of diet, have been shown to impact on 
the rates of diabetes vascular disease and cancers (29).  The challenge is therefore to 
educate and support patients to make positive changes to lifestyles to reduce the 
burden of co-morbidities and improve life expectancy in socially deprived areas.   
 
What else can we do to improve clinical outcomes related to social inequalities?  In 
addition to the impact of co-morbidity, poor medical outcomes associated with social 
deprivation have been ascribed with inequality of access to specialist services. 
Specifically access to specialist cardiology services has also been shown to be 
reduced in the socioeconomically deprived cohort which contributes to poor outcome 
(30).   Access to specialist services have also been demonstrated to influence outcome 
in nephrology, with patients from socially deprived less likely to receive access 
transplant waiting lists and be considered for living related a kidney transplantation 
(18, 19).  Recent data generated in Wales suggest that access to medical services also 
affects AKI outcomes.   Almost half of people that present with Community acquired 
AKI have a measure of renal function in the month prior to the AKI episode 
demonstrating that they are already known to medical services. This suggest that for 
some patient AKI may be predictable and potentially be avoided (31).  Poor outcome 
for CA-AKI in primary care has also been associated with lack of early recognition, 
work which has led to the recommendation that a clinical review and repeat 
measurement of renal function should be undertaken within 7 days for all patients 
with an AKI electronic alert in primary care (32). Poor outcome for AKI has also 
been described for patients in whom AKI is detected at the weekend, and effect 
related to reduced admission rates and access to hospital in-patient care during 
weekends (33).  Although there is data to support an effect of social deprivation on 
access to hospital services at the weekend (34, 35), no previous work has described  
the effect of social deprivation on AKI weekend presentation and outcome.  Previous 
studies suggest that CA-AKI detected on the weekend is associated with a worse 
outcome (33).  In the current study a higher proportion of CA-AKI was detected at the 
weekend in socially deprived areas, a factor therefore likely to influence mortality 
following AKI in socially deprived regions.  
 Although this study is to our knowledge the first national study to define the 
relationship between measures of social deprivation and AKI, its findings need to 
be qualified by its limitations.  As the e-alert system is IT driven it lacks 
“intelligence” and therefore there is no clinical context applied.  Using an IT 
based approach precludes inclusion of clinical information, such as patient co-
morbidity and linkage to primary care data sets, and lacks the detail of the cause 
of AKI, the need for RRT, and does not shed light on the cause of death. 
Similarly, this method of identification of AKI does not allow details on the date 
and time of admission to hospital, meaning the diagnosis of HA-AKI is 
dependent on a previous test of renal function requested from an in-patient 
setting.  The study is also limited in that any patient presenting with AKI but 
without a measurement of renal function in the previous 365 days will not be 
included.  Similarly, the reliance on a definition	 of	 AKI	 based	 on	 serial	
changes	in	serum	creatinine	does	not	take	into	account	urine	output	based	
AKI	 diagnosis	 which	 may	 also	 lead	 failure	 to	 include	 all	 cases	 of	 AKI.		
Despite these limitation, our data suggest that in addition to lifestyle and modification 
of co-morbidities, the availability and accessibility of resources and services may 
impact on AKI outcome measures.  Careful consideration is therefore needed in order 
to optimize resource planning to address caseload for clinician to reflect significant 
difference in workload which reflect the clinical needs of patients in deprived and 
affluent.    It is therefore likely that to improve outcomes there is a need for both 
social and medical interventions and the needs of patients may be somewhat different 
in different geographical areas.  In order to improve AKI outcomes further research is 
needed to identify key modifiable targets for intervention which may address patients 
needs from different socio-economic backgrounds.   
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Figure Legends: 
Figure 1:   The relationship between the incidence of AKI and social deprivations as 
measured by WIMD percentile.  [A] Total AKI incidence rate.  [B] Incidence of 
Community acquired AKI.  [C] Incidence of Hospital acquired AKI.  [D] Average 
number of AKI episodes per patient during the study period.  WIMD, Welsh Index of 
Multiple Deprivation, where percentile 1 is the most deprived and percentile 100 is 
the least deprived. 
 
Figure 2:  Correlation of Percentage of total AKI [A] or community acquired AKI [B] 
generating an electronic AKI alert on a weekend (Saturday and Sunday) and patient 
socioeconomic status as assessed by WIMD percentile.  
 
Figure 3:  Correlation of percentage of patients who died within 90-day of all incident 
AKI patients [A], incident community acquired AKI patients [B] or incident hospital 
acquired AKI patients [C].  Community acquired AKI includes a total of 41 731 
patients, Hospital acquired AKI includes a total of 32 692 patients.   
 
Figure 4:  Kaplan-Meier	 survival	 curves	 for	 AKI	 patients	 stratified	 by	 WIMD	
quartile.	 	 Quartile	 1	 represents	 the	 most	 deprived	 and	 quartile	 4	 the	 most	
affluent	ranked	geographical	areas.		Data	was	censored	at	two	years.	 
 
Figure 5:  Correlation of measures of AKI severity at presentation and socioeconomic 
status.  Severity of AKI as assessed by the percentage presenting with AKI 3 or the 
combined percentage presenting with AKI stage 2 and 3, of all patients [A], patients 
with community acquired AKI [B], hospital acquired AKI [C] and social deprivation.  
Severity of AKI was also determined by the percentage of patients who progressed to 
a higher AKI stage, defined as a peak AKI stage higher that the incident AKI stage or 
for stage 3 alerts an increase≥50% from the SCr generating the alert [C].   
 
Figure 6:  Correlation of age of all incident patients [A], patients with community 
acquired AKI [B] and hospital acquired AKI [C] at presentation and socioeconomic 
status measured by WIMD percentile.    
 
Figure 7:  Kaplan-Meier	survival	curves	for	for patients aged <65 years (A) of age 
and ≥65 years of age (B) stratified	by	WIMD	quartile.	 	Quartile	1	represents	 the	
most	deprived	and	quartile	4	the	most	affluent	ranked	geographical	areas.		Data	
was	censored	at	two	years.	
 
Figure 8:  Correlation between the percentage of AKI patients with pre-existing 
Chronic Kidney Disease [A] and previous measure of renal function in the month 
prior to presentation of CA-AKI [B] and WIMD ranking.  
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